Talking About Tumors with Ryann and Ryan - A medical oncology podcast
Talking About Tumors
Designed for residents and fellows to provide an overview of the clinical practice and evidence behind management of each individual tumor site. Hematology/Oncology, evidence based medicine, education, chemotherapy, immunotherapy, cancer
03_12 Head and Neck Cancer – Background and adjuvant considerations October 31, 2023
03_11 Mesothelioma and a bit of Large Cell Neuroendocrine CarcinomaOctober 11, 2023
03_10 Small cell lung cancerSeptember 17, 2023
03_09 Stage III NSCLC for the Medical Oncologist August 30, 2023
03_08 ADAURA TrialAugust 16, 2023
03_07 (Neo)Adjuvant NSCLC July 26, 2023
03_06 Driver Mutations in Advanced NSCLCJuly 06, 2023
03_05 NSCLC metastatic without driver mutationsJune 20, 2023
03_04 Overview of Lung CancerMay 31, 2023
03_03 Metastatic MelanomaMay 09, 2023
03_02 Localized MelanomaApril 14, 2023
03_01 The era of immune checkpoint inhibitorsMarch 27, 2023
02_10 BRCA Positive Breast Cancer in the ClinicMarch 14, 2023
02_09 Triple Negative Breast CancerMarch 01, 2023
02_08 Early HER-2 positive breast cancerFebruary 14, 2023
02_07 HER-2 positive breast cancer: Considerations in advanced diseaseJanuary 19, 2023
02_06 HER-2 Low Breast Cancer and Sacutuzumab GovetecanDecember 29, 2022
02_05 Management of Metastatic Hormone Positive Breast CancerDecember 05, 2022
02_04 Recurrence risk scores and CDK inhibitors for Early Breast CancerNovember 18, 2022
02_03 Adjuvant endocrine therapy for early breast cancerOctober 29, 2022
02_02 Chemotherapy Options and Bisphosphonates in Early Breast CancerOctober 10, 2022
02_01 An Overview of Considerations for Early Breast CancerSeptember 26, 2022
01_13 Anal Squamous Cell CarcinomaSeptember 13, 2022
01_12 Rectal Cancer – TNT (Total Neoadjuvant Therapy) and ImmunotherapyAugust 31, 2022
01_11 Rectal Cancer – An Overview of the Challenges and Basics of ManagementAugust 17, 2022